As Medical Director, Stephen D. Cassivi leads the partnership’s clinical venture in London alongside his role as a consultant in the Division of General Thoracic Surgery, Department of Surgery at Mayo Clinic. He joined the staff of Mayo Clinic in 2002 and holds the academic rank of professor of surgery, Mayo Clinic College of Medicine and Science. He also serves as the medical director of the Mayo Clinic division of Brand Strategy and Creative Studio. Dr. Cassivi’s clinical interests and experience span the spectrum of thoracic surgery with a specific expertise in minimally invasive thoracic surgery. His research focuses include gene therapy in lung transplantation/lung preservation, measures of quality in surgical outcomes, regenerative surgical therapies, and brachytherapy for lung cancer. He remains active in education and has authored and co-authored over 200 scientific journal articles and other written publications. Dr. Cassivi has also served as Vice Chair of the Department of Surgery as well as on numerous committees at Mayo Clinic, including the Surgical Executive Committee, the Mayo Clinic Cancer Care Advisory Council, and the Outpatient Practice Executive Committee.
The multi-award-winning US-based not-for-profit clinic serves more than 1.3 million patients worldwide, and invests more than US $1bn in clinical research and education each year. Mayo Clinic was ranked the best hospital in the US by the US News and World Report in 2016, 2017 and 2018.